KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in id-KLH (26)

Monday
Mar132006

NCT00302861

A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Conditions: B-Cell Chronic Lymphocytic Leukemia
Sponsors: Genitope Corporation
Phase I, II

Tuesday
Nov222005

NCT00258336

Thursday
Mar032005

NCT00104819

Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma

Conditions: Lymphoma
Sponsors: Favrille, National Cancer Insitute (NCI)
Phase II

Wednesday
Aug042004

NCT00089115

Tuesday
Nov042003

NCT00071955

Tuesday
May062003

NCT00060164

Rituximab, Autologous Vaccine Therapy, and Sargramostim in Treating Patients With Recurrent or Refractory Follicular B-Cell Lymphoma

Conditions:  Lymphoma
Sponsors:  Univeristy Hospitals Seidman Cancer Center, National Cancer Institute (NCI)
Phase II

Monday
Jul152002

NCT00041730

Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma

Conditions: Non-Hodgkin's Lymphoma
Sponsors: Favrille
Phase II

Saturday
Mar092002

NCT00036426

Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma

Conditions: Lymphmoa, Low-Grade
Sponsors: Favrille
Phase II

Wednesday
Jun062001

NCT00017290

Monday
Nov062000

NCT00006478